Determination of kanamycin concentration in serum by substrate-labeled fluorescent immunoassay.
A homogeneous substrate-labeled fluorescent immunoassay was developed for the measurement of kanamycin concentrations in serum. A fluorogenic drug reagent (FDR) (beta-galactosyl-umbelliferone-tobramycin) was prepared that is nonfluorescent under the conditions of the assay but is hydrolyzed upon cat...
Сохранить в:
| Опубликовано в:: | Antimicrob Agents Chemother |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology (ASM)
1986
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180483/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3524437/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.29.6.961 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
